Tempus AI is a healthcare-oriented artificial intelligence company. Spruce Point Capital Management released a report ...

This maneuver has the appearance of potentially round-tripping capital to create revenue and ... and images in Spruce Point’s full report. As a reminder, our full report, along with its ...

Warns That Tempus Management and Board Members Have a History Together of Promoting Disruptive Technology Companies Which Have Frequently Resulted in Financial Restatements and Shareholder Losses ...

An investment management firm known for short-selling the stocks it speaks against is now targeting a high-risk, high-reward ...

Shares of Tempus AI, Inc. fell over 19% in intraday trading on Wednesday, May 28, 2025, after Spruce Point Capital Management published a report alleging that Tempus AI is engaging in "aggressive and ...

Spruce Point said Tempus’ revenue quality should be carefully scrutinized, because of signs of "aggressive accounting." ...

Tempus AI offers artificial-intelligence-powered tools to streamline the drug development and launch process. Shares have performed reasonably well -- though erratically -- since last year’s IPO ...

Shares of Tempus AI ( TEM -18.07%) are falling on Wednesday. One of Cathie Wood's largest holdings, the company's stock ...

All AstroNova Stakeholders Invited to Meet and Interact with Askeladden’s Board Candidates Askeladden Nominees Have Specific ...

Pomerantz LLP is investigating claims on behalf of investors of  Tempus AI, Inc. ("Tempus" or the "Company") . Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or ...